US medical technology company Stryker is investing approximately US$400m (£300m) in UK surgical robotics developer CMR Surgical, alongside securing an exclusive option to acquire the remaining equity in the business. The agreement also gives Stryker exclusive US commercial agency rights for CMR’s Versius surgical robotics portfolio, positioning it to expand sales of the system in […]
The post Stryker invests US$400m in CMR Surgical and secures option to acquire business appeared first on Pharmafile.